Reference
Shi VJ, et al. Cutaneous vasculopathy as an adverse effect of the anti-vascular endothelial growth factor agent axitinib. JAMA Dermatology 152: 222-223, No. 2, Feb 2016. Available from: URL: http://doi.org/10.1001/jamadermatol.2015.3209 - USA
Rights and permissions
About this article
Cite this article
Axitinib. Reactions Weekly 1592, 40 (2016). https://doi.org/10.1007/s40278-016-15468-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-016-15468-9